The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Skyline Therapeutics, an innovation-driven gene therapy company committed to developing unique and novel solutions for rare and severe diseases, ...
read more
Biosyngen, an immune-oncology company with technology targeting the unmet medical needs in solid tumor and lymphoma treatment, announced the official ...
read more
Donaldson Company, Inc., a worldwide provider of filtration products and solutions announced the acquisition of Univercells Technologies, a global ...
read more
Synthego announced a partnership with ATCC to provide researchers with an extensive collection of mammalian and mouse cell lines for gene editing ...
read more
Curia has signed a licensing agreement with MilliporeSigma, the North American Life Sciences Business of Merck KGaA, Darmstadt, Germany, that enables ...
read more
AstraZeneca has entered into a collaboration, and exclusive option and license agreement with Quell Therapeutics to develop multiple engineered T-...
read more
Modality Solutions and CSafe announced a strategic partnership to provide a next-generation cold chain solution for cell and gene therapies (CGTs).
read more
NewBiologix SA launched as a technology innovation company developing a proprietary and breakthrough platform for the advanced engineering of cell ...
read more
MicrofluidX, a UK-based provider of bioreactors for cell biology research and cell therapy manufacturing, announced a joint research project with ...
read more
GRI Bio announced the completion of the previously announced merger between Vallon Pharmaceuticals, Inc
read more
Thermo Fisher Scientific Inc. and the University of California, San Francisco (UCSF), will accelerate advanced cell therapies for difficult to treat ...
read more
Cullinan Oncology announced the FDA cleared its Investigational New Drug (IND) application for CLN-617, a fusion protein comprised of two potent and ...
read more
Curia, a contract research, development and manufacturing organization, announced a collaboration with Corning Incorporated to expand and accelerate ...
read more
Northwest Biotherapeutics and Advent BioServices, a leading contract development and manufacturing organization (CDMO) based in the UK, jointly ...
read more
Wednesday, March 15, 2023
Artisan Bio announced an extension of its research collaboration with Takeda which leverages Artisan's genome editing technology. The amended ...
read more